Data in Tables 14-15 are based on the following analyses:
Proportion of patients in SHDC receiving a TST before or during 1998.
Among patients interviewed in SHAS in 1999, proportion with no prior history of TB and no prior positive TST who received a TST.
Among newly diagnosed HIV/AIDS patients in MOPTB ever receiving a TST after HIV diagnosis.
Data Source
Total
White
Black
Hispanic
Asian/Pacific
Islander
American Indian/
Alaska Native
%
Treated/
Eligible
%
Treated/
Eligible
%
Treated/
Eligible
%
Treated/
Eligible
%
Treated/
Eligible
%
Treated/
Eligible
SHDC Site A
55
108/288
55
47/85
52
24/46
—
—
—
—
—
—
SHDC Site B
62
157/253
64
36/56
60
37/62
—
—
—
—
—
—
SHDC Site C
34
127/374
33
35/107
36
32/88
—
—
—
—
—
—
SHAS*
75
1,497/2,002
74
420/568
76
747/978
71
274/386
86
6/7
76
22/29
MOPTB*
50
437/869
56
137/243
49
213/436
44
67/151
—
—
—
—
*The SHAS total contains 34 patients with unknown race/ethnicity. The MOPTB total contains 21 patients with unknown race/ethnicity.
Similar proportions of patients by race/ethnicity received a TST across all data sources.
Differences in the populations represented by the samples at the 3 SHDC sites may account for the difference in receipt of TST (see
Technical Notes). Providers at Sites A and B may provide more HIV-related care and are therefore more likely to provide a TST compared with providers not in or near metropolitan areas at Site C.
Results for racial and ethnic groups with small numerators and/or denominators should be interpreted with caution.
Proportions are not presented for Hispanics, Asian/Pacific Islanders and American Indian/Alaska Natives in SHDC because of small numbers of cases.
Proportions are not presented for Asian/Pacific Islanders and American Indian/Alaska Natives in MOPTB because of small numbers of cases.
